Finance

Lists
1733:TPE
Apex Biotechnology Corp
NT$29.05
-0.51%
(-0.15) 1D
Nov 16, 1:30:01 PM GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 1733...
Open
NT$29.30
High
NT$29.70
Low
NT$29.05
Mkt. cap
2.90B
Avg. vol.
91.11K
Volume
92.11K
Dividend
4.48%
Quarterly dividend
NT$0.32
Ex-dividend date
Jun 9, 2026
P/E ratio
15.77
52-wk high
NT$33.10
52-wk low
NT$28.00
EPS
NT$1.84
Shares outstanding
99.69M
No. of employees
641
Open
NT$29.30
High
NT$29.70
Low
NT$29.05
Mkt. cap
2.90B
Avg. vol.
91.11K
Volume
92.11K
Dividend
4.48%
Quarterly dividend
NT$0.32
Ex-dividend date
Jun 9, 2026
P/E ratio
15.77
52-wk high
NT$33.10
52-wk low
NT$28.00
EPS
NT$1.84
Shares outstanding
99.69M
No. of employees
641
News stories
From web sources and news partners
About Apex Biotechnology Corp
CEO-
Employees641
Founded1997
Headquarters-
SectorHealth Care
IndustryMedical device
Previous reportsAll values in TWD
Loading Previous Earnings...
Revenue
Net income
All values in TWD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
438.99M
519.72M
470.65M
428.30M
Cost of goods sold
306.63M
344.06M
312.37M
303.12M
Cost of revenue
306.63M
344.06M
312.37M
303.12M
Research and development expenses
36.02M
37.23M
49.84M
41.32M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
62.79M
60.29M
63.81M
62.73M
Operating expense
99.12M
88.45M
113.66M
99.76M
Total operating expenses
405.75M
432.51M
426.02M
402.87M
Operating income
33.24M
87.21M
44.63M
25.42M
Other non operating income
894.00K
191.00K
591.00K
-4.40M
EBT including unusual items
58.17M
86.91M
44.68M
20.18M
EBT excluding unusual items
57.52M
90.23M
41.45M
20.18M
Income tax expense
7.97M
5.54M
7.84M
2.53M
Effective tax rate
13.70%
6.38%
17.54%
12.54%
Other operating expenses
-
-
-
-
Net income
50.08M
81.28M
36.78M
17.47M
Net profit margin
11.41%
15.64%
7.81%
4.08%
Earnings per share
-
-
-
-
Interest and investment income
1.49M
219.00K
4.56M
36.00K
Interest expense
-822.00K
-829.00K
-804.00K
-876.00K
Net interest expenses
665.00K
-610.00K
3.75M
-840.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
45.47M
99.16M
56.25M
44.94M
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps